Barasch, A., Cunha-Cruz, J., Curro, F., DeRouen, T., Gilbert, G.H., Hujoel, P., et al. (2013) Dental Risk Factors for Osteonecrosis of the Jaws: A CONDOR Case-Control Study. Clinical Oral Investigations, 17, 1839-1845.
https://doi.org/10.1007/s00784-012-0880-4

has been cited by the following article:

• TITLE: Bisphosphonates Zoledronate and Alendronate for the Management of Postmenopausal Osteoporosis

  AUTHORS: IsraaIsraa Ahmed Radwan, Nahed Sedky Korany, Bassant Adel Ezzat

  KEYWORDS: Bisphosphonates, Alendronate, Zoledronate, Postmenopausal Osteoporosis

  JOURNAL NAME: Case Reports in Clinical Medicine, Vol.7 No.5, May 10, 2018

  ABSTRACT: Bisphosphonates are among the most frequently used antiresorptive drugs for the management of postmenopausal osteoporosis. We review here two of the commonly used bisphosphonates zoledronate and alendronate.